These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 15868427)
1. Effect of axillary lymphadenectomy on breast carcinoma survival. Joslyn SA; Konety BR Breast Cancer Res Treat; 2005 May; 91(1):11-8. PubMed ID: 15868427 [TBL] [Abstract][Full Text] [Related]
2. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Wright JL; Lin DW; Porter MP Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515 [TBL] [Abstract][Full Text] [Related]
3. Breast carcinoma survival in Europe and the United States. Sant M; Allemani C; Berrino F; Coleman MP; Aareleid T; Chaplain G; Coebergh JW; Colonna M; Crosignani P; Danzon A; Federico M; Gafà L; Grosclaude P; Hédelin G; Macè-Lesech J; Garcia CM; Møller H; Paci E; Raverdy N; Tretarre B; Williams EM; Cancer; 2004 Feb; 100(4):715-22. PubMed ID: 14770426 [TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825 [TBL] [Abstract][Full Text] [Related]
5. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. Konety BR; Joslyn SA; O'Donnell MA J Urol; 2003 Mar; 169(3):946-50. PubMed ID: 12576819 [TBL] [Abstract][Full Text] [Related]
6. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207 [TBL] [Abstract][Full Text] [Related]
7. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma. Kuru B; Bozgul M Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505 [TBL] [Abstract][Full Text] [Related]
8. Significance of micrometastases on the survival of women with T1 breast cancer. Maibenco DC; Dombi GW; Kau TY; Severson RK Cancer; 2006 Sep; 107(6):1234-9. PubMed ID: 16900518 [TBL] [Abstract][Full Text] [Related]
9. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer. Petrik DW; McCready DR; Sawka CA; Goel V J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062 [TBL] [Abstract][Full Text] [Related]
10. Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance? Salama JK; Heimann R; Lin F; Mehta N; Chmura SJ; Singh R; Kao J Cancer; 2005 Feb; 103(4):664-71. PubMed ID: 15641038 [TBL] [Abstract][Full Text] [Related]
11. The lymph node ratio as prognostic factor in node-positive breast cancer. Voordeckers M; Vinh-Hung V; Van de Steene J; Lamote J; Storme G Radiother Oncol; 2004 Mar; 70(3):225-30. PubMed ID: 15064006 [TBL] [Abstract][Full Text] [Related]
12. Ratios of involved nodes in early breast cancer. Vinh-Hung V; Verschraegen C; Promish DI; Cserni G; Van de Steene J; Tai P; Vlastos G; Voordeckers M; Storme G; Royce M Breast Cancer Res; 2004; 6(6):R680-8. PubMed ID: 15535850 [TBL] [Abstract][Full Text] [Related]
13. Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival. Grabau D; Jensen MB; Rank F; Blichert-Toft M APMIS; 2007 Jul; 115(7):828-37. PubMed ID: 17614850 [TBL] [Abstract][Full Text] [Related]
14. Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation. Reddy SG; Kiel KD Breast J; 2007; 13(1):12-8. PubMed ID: 17214788 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer. Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475 [TBL] [Abstract][Full Text] [Related]
16. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Nemani D; Mitra N; Guo M; Lin L Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808 [TBL] [Abstract][Full Text] [Related]
17. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151 [TBL] [Abstract][Full Text] [Related]
18. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Parthasarathy A; Cheung MK; Osann K; Husain A; Teng NN; Berek JS; Kapp DS; Chan JK Gynecol Oncol; 2006 Dec; 103(3):1095-9. PubMed ID: 16889821 [TBL] [Abstract][Full Text] [Related]
19. Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National Surveillance, Epidemiology, and End Results database. Joslyn SA; Sirintrapun SJ; Konety BR Urology; 2005 Apr; 65(4):675-80. PubMed ID: 15833507 [TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Chen SL; Hoehne FM; Giuliano AE Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]